Citigroup’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$710K Sell
229,814
-32,022
-12% -$98.9K ﹤0.01% 2712
2025
Q1
$914K Buy
261,836
+74,116
+39% +$259K ﹤0.01% 2598
2024
Q4
$614K Buy
187,720
+78,669
+72% +$257K ﹤0.01% 2893
2024
Q3
$420K Sell
109,051
-1,032,262
-90% -$3.97M ﹤0.01% 3096
2024
Q2
$3.53M Buy
1,141,313
+914,425
+403% +$2.83M ﹤0.01% 1374
2024
Q1
$585K Buy
226,888
+205,603
+966% +$530K ﹤0.01% 2753
2023
Q4
$53.2K Sell
21,285
-117,571
-85% -$294K ﹤0.01% 3740
2023
Q3
$282K Buy
138,856
+61,098
+79% +$124K ﹤0.01% 2781
2023
Q2
$179K Buy
77,758
+75,978
+4,268% +$175K ﹤0.01% 3277
2023
Q1
$5.39K Sell
1,780
-993
-36% -$3.01K ﹤0.01% 4240
2022
Q4
$6.46K Sell
2,773
-654
-19% -$1.52K ﹤0.01% 4252
2022
Q3
$7K Sell
3,427
-6,170
-64% -$12.6K ﹤0.01% 4338
2022
Q2
$26K Buy
9,597
+2,803
+41% +$7.59K ﹤0.01% 4159
2022
Q1
$20K Sell
6,794
-17,860
-72% -$52.6K ﹤0.01% 4394
2021
Q4
$96K Buy
24,654
+9,975
+68% +$38.8K ﹤0.01% 3989
2021
Q3
$63K Buy
14,679
+5,117
+54% +$22K ﹤0.01% 3873
2021
Q2
$29K Sell
9,562
-20,828
-69% -$63.2K ﹤0.01% 4421
2021
Q1
$101K Sell
30,390
-24,880
-45% -$82.7K ﹤0.01% 3700
2020
Q4
$196K Buy
55,270
+46,724
+547% +$166K ﹤0.01% 3248
2020
Q3
$27K Buy
8,546
+5,600
+190% +$17.7K ﹤0.01% 3774
2020
Q2
$5K Sell
2,946
-100
-3% -$170 ﹤0.01% 4802
2020
Q1
$3K Sell
3,046
-2,714
-47% -$2.67K ﹤0.01% 4873
2019
Q4
$16K Sell
5,760
-2,168
-27% -$6.02K ﹤0.01% 4556
2019
Q3
$12K Sell
7,928
-4,985
-39% -$7.55K ﹤0.01% 4482
2019
Q2
$27K Buy
12,913
+3,127
+32% +$6.54K ﹤0.01% 4446
2019
Q1
$35K Sell
9,786
-759
-7% -$2.72K ﹤0.01% 4238
2018
Q4
$41K Sell
10,545
-13,579
-56% -$52.8K ﹤0.01% 4034
2018
Q3
$228K Buy
24,124
+14,751
+157% +$139K ﹤0.01% 3074
2018
Q2
$68K Buy
9,373
+5,687
+154% +$41.3K ﹤0.01% 3678
2018
Q1
$18K Buy
3,686
+702
+24% +$3.43K ﹤0.01% 4257
2017
Q4
$15K Sell
2,984
-10,012
-77% -$50.3K ﹤0.01% 4343
2017
Q3
$81K Buy
12,996
+2,000
+18% +$12.5K ﹤0.01% 3472
2017
Q2
$40K Sell
10,996
-2,364
-18% -$8.6K ﹤0.01% 3685
2017
Q1
$44K Sell
13,360
-51,800
-79% -$171K ﹤0.01% 3727
2016
Q4
$160K Buy
65,160
+27,700
+74% +$68K ﹤0.01% 3695
2016
Q3
$129K Buy
37,460
+600
+2% +$2.07K ﹤0.01% 3264
2016
Q2
$128K Buy
36,860
+3,959
+12% +$13.7K ﹤0.01% 3155
2016
Q1
$136K Buy
32,901
+19,851
+152% +$82.1K ﹤0.01% 3769
2015
Q4
$58K Sell
13,050
-3,982
-23% -$17.7K ﹤0.01% 3968
2015
Q3
$103K Sell
17,032
-25,150
-60% -$152K ﹤0.01% 3164
2015
Q2
$501K Sell
42,182
-45,770
-52% -$544K ﹤0.01% 2153
2015
Q1
$1.54M Sell
87,952
-1,273
-1% -$22.2K ﹤0.01% 1480
2014
Q4
$1.37M Buy
89,225
+87,743
+5,921% +$1.34M ﹤0.01% 1541
2014
Q3
$31K Sell
1,482
-1,165
-44% -$24.4K ﹤0.01% 3982
2014
Q2
$35K Buy
2,647
+650
+33% +$8.6K ﹤0.01% 3790
2014
Q1
$44K Buy
1,997
+1,162
+139% +$25.6K ﹤0.01% 4034
2013
Q4
$6K Buy
+835
New +$6K ﹤0.01% 4967
2013
Q3
Sell
-20
Closed 5128
2013
Q2
$0 Buy
+20
New ﹤0.01% 5076